The "last mile" of the "AI + Medicine" sector lies in the data that hospitals are reluctant to mention: the medical legal service platform YCDY CN has completed its seed round financing.
Deeply Cultivating AI for Medical-related Legal Affairs and the Underlying Layer of Medical Data
The AI enterprise in the medical-related legal track, "Medical Hammer Determines Cause", recently completed its seed round financing. This round is jointly invested by Ruiying Medical Examination and Yun Bio, and the funds will be mainly used for the iterative optimization of its core AI & expert collaboration system, in-depth polishing of three types of proprietary datasets, expansion of partners and opening of offline stores.
Interdisciplinary Medical and Legal Team and Products
The founding team of "Medical Hammer Determines Cause" has an interdisciplinary composite background: Founder LI Xiyi graduated from Fudan University with a major in clinical oncology, he previously founded the internet medical platform "Famous Doctor Here" APP and the second opinion platform "Ask More Doctors", and he is also a practicing lawyer in China who rarely holds dual clinical qualifications in both traditional Chinese medicine and Western medicine. COO LI Rui graduated from the Medical School of Peking University majoring in surgical system, has been deeply engaged in clinical surgical education for more than 20 years, is a leading figure in China's medical education sector, and also the head of a large-scale nationally renowned medical examination training institution. CTO YU Zhenyu is a Doctor of Management Engineering from Tongji University, once served as a visiting scholar in the AI group of Oregon State University, and has long been deeply engaged in system modeling and cutting-edge large model applications. Other members of the team are composed of experts in cross-cutting fields such as medicine, law, forensic medicine and forensic science.
"Medical Hammer Determines Cause" builds its own AI & expert collaboration system, and empowers the whole chain of handling medical-related cases with professional medical and legal capabilities: covering the positioning of medical record contradictions, benchmarking of diagnosis and treatment specifications, judgment of medical fault and causal relationship, compensation calculation, evidence sorting and appraisal statement writing, as well as non-litigation/pre-litigation full-process legal support such as legal provision retrieval and similar case matching. Its business scope also extends to other medical-related dispute scenarios such as personal injury in traffic accidents and commercial insurance work-related injuries.
Track Logic: Why a Professional "Medical Stratum" is Needed
Medical damage cases have returned from the historical "institution-side burden of proof" to the fault liability principle of "patient self-proof". Professional medical competence is no longer a "litigation skill", but an institutional rigid demand under the change of burden of proof and the principle of court disposition. Professional medical judgment directly determines the strategy selection of such cases. With the aging of the population, traffic accident cases have also become more complex, raising their medical threshold. The "integration of traffic accident handling" further makes medical intervention an irreplaceable competitiveness in dealing with personal injury in traffic accidents. In addition, there are very few lawyers with medical backgrounds, so there is an urgent need for a professional "medical stratum" to empower all practicing lawyers and break through the limitations of individual case handling. The construction of the rule of law and the new national standard for electronic medical records have strengthened the supervision of non-medical links such as tampering and deleting medical records and negative process confrontation, returning medical-related disputes to medical interpretation, which further highlights the necessity of professional medical support.
Overseas capital has long verified this track with real money: top venture capital firms such as a16z have successively heavily bet on medical-related AI legal enterprises such as EvenUp, EveLegal, and Supio, unanimously optimistic about the value reshaping of their proprietary medical-related legal data in the AI era. However, there is no leading monopoly enterprise in this track in China.
Different from general AI legal tools, "Medical Hammer Determines Cause", relying on its own team advantage of integrating medicine and law, in addition to providing professional medical analysis and legal support, has exclusively precipitated three vertical datasets, forming a highly advantageous differentiated competitive barrier beyond legal AI.
Appearance of "Medical Hammer Determines Cause" offline store (Source/Enterprise)
The Three Major Datasets That "Medical Hammer Determines Cause" is Committed to Polishing
(I) Medical Deviation Dataset: The Safety Base of AI Healthcare
The "last mile" of AI healthcare is to solve the fatal hallucination problem, which precisely requires real-world medical deviation data for feedback and correction. China has more than 10 billion annual diagnosis and treatment visits, and the accompanying medical errors/deviations such as missed diagnosis and misdiagnosis are the inevitable distribution of the system, which already has the scale premise to form the world's largest "medical deviation dataset". However, due to the lack of a mandatory reporting system and reputation considerations, hospitals often hide the details of their own medical disputes, and have no motivation to disclose them to the outside world. Through the judicial rights protection on the plaintiff side, "Medical Hammer Determines Cause" collides with the "negative sample" data of medical deviation hidden inside the hospital and the fault boundary labels after judicial game, helping the model to compress fault tolerance and correct hallucinations, and build a safety base for the native implementation of AI healthcare.
(II) Differentiated Curative Effect Dataset: The Clinical Engine of AI Drug Development
The initiation and resolution of medical disputes are inseparable from the systematic evaluation of diagnosis and treatment behaviors, which is essentially the second diagnosis and treatment opinion with the highest confrontation. The core features of the second opinion: excessive medical treatment, rationality assessment of bills, etc., are also included in the scope of judicial appraisal. The composite team of "Medical Hammer Determines Cause" derived from clinical practice brings value far beyond disputes: it can not only identify and avoid unnecessary litigation burden, but also gain insight into the disease progression under different diagnosis and treatment paths through second opinions and independent follow-up, and discover horizontal and vertical cohorts of differentiated curative effects.
"Calculating molecular structure" is no longer a bottleneck. The "last mile" of AI pharmaceutical development is stuck in "proving human efficacy": long cycle, difficult subject enrollment, and diluted signals when the population is averaged. In addition to dispute handling, "Medical Hammer Determines Cause" condenses differentiated curative effect data with second diagnosis and treatment opinions, providing a real-world anchor for enrollment optimization and clinical design, and is committed to improving the clinical R&D efficiency of AI pharmaceutical development.
(III) Objective Restoration Dataset of Clinical Skills: Medically Trusted Evidence for AI Search
Most of the current medical data is not a real reproduction of clinical skills, but templated and administrative medical records. "Medical Hammer Determines Cause" assists patients in safeguarding their rights, and can completely and objectively restore the details of diagnosis and treatment — the traceable fact base anchored by judicial-level consensus, high compliance from direct authorization by patients rather than indirect authorization by hospitals, structured expert annotation, negative risk signals, etc., directly respond to the requirements of AI search for information sources. Thanks to its ecological niche on the patient side, it completely moves AI medical search from bidding ranking and paid optimization back to the fact layer that objectively restores clinical skills, so that users are no longer trapped in various medical advertisement links that are difficult to distinguish between true and false: this is a medical trusted evidence layer directly built on the requirements of AI search.
"Medical Hammer Determines Cause" AI & Expert Collaboration System (Source/Enterprise)
Keep the "Last Mile" of "AI + Pharmaceutical" in China's Medical System
The CEO of Ant Group once confessed at the Bund Summit that the "last mile" of AI medical implementation faces three major problems: high-quality data, hallucination suppression, and medical ethics. "Medical Hammer Determines Cause" takes judicial evidence-level medical data as the backbone, takes compliance and ethics of direct patient authorization as the boundary, and takes negative sample data of judicial restoration and hallucination correction as the blade — the three are interlocked, and gives its own answer with the medical deviation dataset.
China has the world's largest scale of diagnosis and treatment data, which will also be accompanied by the world's largest scale of "medical deviation data" that can feed back the model to correct hallucinations but hospitals are reluctant to mention. This dark side of data that hospitals are unwilling to disclose is the starting point for "Medical Hammer Determines Cause" to set off. With the dual ecology of "damage + curative effect" in hand, "Medical Hammer Determines Cause" not only chooses to stand on the track of medical-related legal AI, but also looks further: starting from negative samples, it builds the OS-level data underlying layer for AI pharmaceuticals, and keeps the discourse power to define the "last mile" of the global "AI + Pharmaceutical" industry in China's medical system.